# CAPTURE 2 Post-Marketing Registry

> **NCT00302237** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 6426 (actual)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DEVICE:** RX ACCULINK, RX ACCUNET Embolic Protection System

## Key facts

- **NCT ID:** NCT00302237
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 6426 (ACTUAL)
- **Last updated:** 2012-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302237, "CAPTURE 2 Post-Marketing Registry". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00302237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*